BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1.06 Cr |
| Mar2024 | ₹-0.85 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹-4.81 Cr |
| Mar2021 | ₹12 Cr |
How is Cash Flow from Financing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.06 Cr | Positive | |
| Mar2024 | ₹-0.85 Cr | Negative | |
| Mar2023 | ₹10 Cr | Positive | |
| Mar2022 | ₹-4.81 Cr | Negative | |
| Mar2021 | ₹12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹260.2 Cr | -5.3% | -1.1% | 40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -5.3% |
-1.1% |
40.2% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses